Clinical Trial Update: Tadalafil in Subjects With Mild to Moderate Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tadalafil in adults with mild to moderate hypertension has been completed. The study was sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypertension | Phase 2 | Status: COMPLETED